Annovis Bio, Inc. (ANVS) stock

ANVSNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30

$0.93+0.08 (+9.31%)

Close on Nov 13, 2026Market cap $39.46MP/E –Yield –

Earnings

Annovis Bio's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report

Mar 15, 2027

Q4 FY2026 · estimated, after the close

Revenue, Q3 FY2026

–

EPS, Q3 FY2026

-$0.22

-$0.37 a year earlier

Latest guidance

None

No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Annovis Bio's earnings releases, newest first

Quarter	Reported	Revenue	YoY	EPS	Source
Q4 FY2026ended Dec 31, 2026	Mar 15, 2027Expected	–	–	–	–
Q3 FY2026ended Sep 30, 2026	Nov 13, 2026after the close	–	–	-$0.22	Release
Q2 FY2026ended Jun 30, 2026	Aug 14, 2026after the close	–	–	-$0.40	Release
Q1 FY2026ended Mar 31, 2026	May 15, 2026after the close	–	–	-$0.63	Release
Q4 FY2025ended Dec 31, 2025	Mar 16, 2026after the close	–	–	–	Release
Q3 FY2025ended Sep 30, 2025	Nov 13, 2025after the close	–	–	-$0.37	Release
Q2 FY2025ended Jun 30, 2025	Aug 12, 2025after the close	–	–	-$0.32	Release
Q1 FY2025ended Mar 31, 2025	May 13, 2025after the close	–	–	-$0.32	Release
Q4 FY2024ended Dec 31, 2024	Mar 21, 2025after the close	–	–	-$0.43	Release
Q3 FY2024ended Sep 30, 2024	Nov 12, 2024before the open	–	–	-$0.97	Release
Q2 FY2024ended Jun 30, 2024	Aug 15, 2024before the open	–	–	-$0.44	Release
Q1 FY2024ended Mar 31, 2024	May 13, 2024after the close	–	–	$0.72	Release
Q4 FY2023ended Dec 31, 2023	Apr 3, 2024after the close	–	–	–	Release
Q3 FY2023ended Sep 30, 2023	Nov 1, 2023during market hours	–	–	–	Release
Q1 FY2023ended Mar 31, 2023	Apr 3, 2023before the open	–	–	–	Release
Q4 FY2022ended Dec 31, 2022	Apr 3, 2023before the open	–	–	–	Release
Q2 FY2022ended Jun 30, 2022	Aug 8, 2022before the open	–	–	–	Release
Q1 FY2022ended Mar 31, 2022	May 4, 2022before the open	–	–	–	Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Annovis Bio has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Annovis Bio puts a forecast in an earnings release, it is listed here with the exact sentence.